Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

PCN Insights, News, Videos, and More

Jonathan Meyer
Videos
07/18/2022
Jonathan M. Meyer, MD, provides insight on initiating long-acting injectables (LAIs) in the schizophrenia treatment plan early and how to discuss this with patients.
Jonathan M. Meyer, MD, provides insight on initiating long-acting injectables (LAIs) in the schizophrenia treatment plan early and how to discuss this with patients.
Jonathan M. Meyer, MD, provides...
07/18/2022
Psych Congress Network
Dr Jonathan M. Meyer.
Videos
07/18/2022
Jonathan M. Meyer, MD, provides insights on how to prioritize patients' goals for treatment and the importance of offering clozapine as an option to treatment resistant patients.
Jonathan M. Meyer, MD, provides insights on how to prioritize patients' goals for treatment and the importance of offering clozapine as an option to treatment resistant patients.
Jonathan M. Meyer, MD, provides...
07/18/2022
Psych Congress Network
Erin Walcykowski
Videos
07/14/2022
In part 1 of this video, Erin Walczykowski, APRN, PMHNP-BC, explains what a BD-I diagnosis means for the patient and their family, and how clinicians can include family and support into a BD-I treatment plan.
In part 1 of this video, Erin Walczykowski, APRN, PMHNP-BC, explains what a BD-I diagnosis means for the patient and their family, and how clinicians can include family and support into a BD-I treatment plan.
In part 1 of this video, Erin...
07/14/2022
Psych Congress Network
Dr Jonathan M Meyer
Videos
07/14/2022
Jonathan Meyer, MD, explains how to account for each patient's unique needs and concerns, frame the benefit of medications around patient goals, and bring up long-acting injectables (LAIs).
Jonathan Meyer, MD, explains how to account for each patient's unique needs and concerns, frame the benefit of medications around patient goals, and bring up long-acting injectables (LAIs).
Jonathan Meyer, MD, explains...
07/14/2022
Psych Congress Network
News
07/13/2022
Jolynn Tumolo
An increased risk of personal histories of trauma combined with a greater vulnerability to alcohol-related deficits in the brain appear to work together to lead to more severe alcohol use disorders in women compared with men.
An increased risk of personal histories of trauma combined with a greater vulnerability to alcohol-related deficits in the brain appear to work together to lead to more severe alcohol use disorders in women compared with men.
An increased risk of personal...
07/13/2022
Psych Congress Network
News
07/13/2022
Jolynn Tumolo
Noradrenergic medications, such as atomoxetine, methylphenidate, and guanfacine, may benefit people with Alzheimer disease and are worthy of further investigation in patients.
Noradrenergic medications, such as atomoxetine, methylphenidate, and guanfacine, may benefit people with Alzheimer disease and are worthy of further investigation in patients.
Noradrenergic medications, such...
07/13/2022
Psych Congress Network
News
07/12/2022
Jolynn Tumolo
Post-traumatic stress disorder (PTSD) was associated with accelerated cognitive decline in middle-aged women, according to a large-scale prospective cohort study.
Post-traumatic stress disorder (PTSD) was associated with accelerated cognitive decline in middle-aged women, according to a large-scale prospective cohort study.
Post-traumatic stress disorder...
07/12/2022
Psych Congress Network
News
07/12/2022
Jolynn Tumolo
A higher intake of fruits and vegetables was inversely associated with inattention in children with attention-deficit/hyperactivity disorder (ADHD), according to a study published in Nutritional Neuroscience.
A higher intake of fruits and vegetables was inversely associated with inattention in children with attention-deficit/hyperactivity disorder (ADHD), according to a study published in Nutritional Neuroscience.
A higher intake of fruits and...
07/12/2022
Psych Congress Network
News
07/12/2022
Jolynn Tumolo
Early trial results offer hope to those suffering from chronic, refractory migraine that failed other treatments, like sumatriptan and other medications.
Early trial results offer hope to those suffering from chronic, refractory migraine that failed other treatments, like sumatriptan and other medications.
Early trial results offer hope...
07/12/2022
Neurology

Advertisement

Advertisement

Advertisement

Advertisement